T. Rowe Price Associates, Inc. 13D and 13G filings for Neurocrine Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX | T. Rowe Price Associates, Inc. | 4,359,645 4.500% | -1,912,085 (-30.49%) | Filing |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX | T. Rowe Price Associates, Inc. | 6,271,730 6.700% | -1,019,567 (-13.98%) | Filing |